Abrocitinib for prurigo nodularis: Clinical efficacy and safety profile.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 4, p. e344, doi. 10.1111/jdv.20322
- By:
- Publication type:
- Article
Works matching AU Zhang, Quanhong
Results: 8
1
2
Treatment of pemphigoid vegetans with abrocitinib.
- Published in:
- Clinical & Experimental Dermatology, 2025, v. 50, n. 2, p. 459, doi. 10.1093/ced/llae411
- By:
- Publication type:
- Article
3
Ineffectiveness of apremilast in moderate‐to‐severe pemphigus: A case series of three patients.
- Published in:
- Australasian Journal of Dermatology, 2024, v. 65, n. 5, p. e121, doi. 10.1111/ajd.14312
- By:
- Publication type:
- Article
4
Current Status and Prospects of Pine Wilt Disease Management with Phytochemicals—A Review.
- Published in:
- Plants (2223-7747), 2024, v. 13, n. 15, p. 2129, doi. 10.3390/plants13152129
- By:
- Publication type:
- Article
5
Case report: Managing pemphigus foliaceus using apremilast without systemic glucocorticosteroids or immunosuppressive agents.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1408116
- By:
- Publication type:
- Article
6
Exploring telitacicept in a patient with pemphigus vulgaris.
- Published in:
- British Journal of Dermatology, 2025, v. 192, n. 5, p. 955, doi. 10.1093/bjd/ljaf023
- By:
- Publication type:
- Article
7
Oral Prednisolone, Apremilast and Human Umbilical Cord Mesenchymal Stem Cells in the Management of Pemphigus Foliaceus.
- Published in:
- Journal of Inflammation Research, 2025, v. 18, p. 5011, doi. 10.2147/JIR.S507799
- By:
- Publication type:
- Article
8
Role of basophils and type 2 inflammation in bullous pemphigoid pathophysiology: a comparative study of blood and blister fluid.
- Published in:
- Immunologic Research, 2025, v. 73, n. 1, p. 1, doi. 10.1007/s12026-025-09617-6
- By:
- Publication type:
- Article